Stay updated on ALD403 in Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.

Latest updates to the ALD403 in Chronic Migraine Clinical Trial page
- CheckyesterdayChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.SummaryDifference1.0%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1%
- Check44 days agoChange DetectedThe page has removed a citation regarding the safety and tolerability of eptinezumab in patients with migraine, which included an erratum reference.SummaryDifference0.3%
Stay in the know with updates to ALD403 in Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.